Abstract
A putative resistant red rice (Oryza sativa) accession, an imidazolinone-resistant rice cultivar (Clearfield), a susceptible red rice accession and a susceptible rice cultivar were evaluated for cross-resistance to imazamox and imazethapyr in a whole-plant response experiment and seed bioassay. Additionally, a 210-bp fragment of the ALS gene was sequenced to identify mutations responsible for resistance. Also, a 574 bp of the ALS gene was sequenced and PCR for detection of the ‘Clearfield allele’ was conducted by the Andalusian Institute of Agricultural Research and Training (IFAPA, Spain). In the whole-plant response experiment, the putative resistant red rice was >23 and >21 times more resistant to imazamox and imazethapyr than the susceptible accession, respectively, whereas the respective resistance factor values based on seed bioassay were 86.4 and 141.7. Also, the respective resistance factor values for the Clearfield rice cultivar were similar with those calculated for putative resistant red rice. Additionally, the sequence of the 210 bp ALS gene fragment from the putative resistant red rice and Clearfield rice cultivar revealed the same amino acid substitution of Ser653Asn in both alleles (homozygous). Furthermore, the sequence of a 574 bp ALS gene fragment and the PCR for detection of the ‘Clearfield allele’ confirmed that the putative resistant red rice is homozygous mutant for the Ser653Asn mutation and provided additional evidence that its genetic background matches that of Clearfield rice. These findings indicate clearly that the insufficient control of the putative resistant red rice with imazamox was due to target-site resistance and particularly due to a point mutation at the Ser653 codon, which is positively identified as having been derived from the Clearfield rice cultivar.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.